TherapeuticsMD
TXMD
83 hedge funds and large institutions have $581M invested in TherapeuticsMD in 2014 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 33 increasing their positions, 12 reducing their positions, and 7 closing their positions.
447% more call options, than puts
Call options by funds: $82K | Put options by funds: $15K
386% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 7
175% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 12
61% more capital invested
Capital invested by funds: $362M → $581M (+$220M)
48% more funds holding
Funds holding: 56 → 83 (+27)
0.31% more ownership
Funds ownership: 0.96% → 1.27% (+0.31%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$33.6M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$27.9M |
| 3 |
Bank of New York Mellon
New York
|
+$26.1M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$15.4M |
| 5 |
CCM
Century Capital Management
Boston,
Massachusetts
|
+$14.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$11.6M |
| 2 |
BC
Broadfin Capital
New York
|
-$10.6M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$8.85M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$928K |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$822K |
TXMD Hedge Fund Activity: Q1 2014 in Review
83 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2014, worth a combined $581M — up 61% from $362M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new TXMD positions and 7 closed out — a net gain of 27 holders — while 33 added to existing stakes and 12 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $33.6M. The largest seller was RA Capital Management, cutting an estimated $11.6M.
- 83 institutional investors held TherapeuticsMD (TXMD) as of Q1 2014, up from 56 in Q4 2013.
- Funds reported $581M of TherapeuticsMD stock for Q1 2014, up 61% quarter-over-quarter.
- 34 funds opened new TherapeuticsMD positions in Q1 2014 and 7 closed out, a net change of +27 holders.
- The largest TherapeuticsMD buyer in Q1 2014 was Fidelity Investments, an estimated $33.6M added.
- The largest TherapeuticsMD seller in Q1 2014 was RA Capital Management, an estimated $11.6M sold.
Based on aggregated 13F filings for Q1 2014.